Global Single-use Bioreactor Market Size (2024 - 2029)

The single-use bioreactor market is projected to experience significant growth over the forecast period, driven by the increasing adoption of single-use technologies due to their cost-effectiveness, lower downtime, and the need for rapid product development and production. The Covid-19 pandemic has notably accelerated the demand for these bioreactors, as they played a crucial role in the swift production of vaccines and treatments. The market's expansion is further supported by advancements in bioprocessing technologies and the standardization of single-use bioreactors in both clinical and industrial applications. Despite these growth drivers, the market may face challenges due to high recurring costs.

Market Size of Global Single-use Bioreactor Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Single Use Bioreactor Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 1.47 Billion
Market Size (2029) USD 2.34 Billion
CAGR (2024 - 2029) 9.70 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Single Use Bioreactor Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single Use Bioreactor Market Analysis

The Global Single-use Bioreactor Market size is estimated at USD 1.47 billion in 2024, and is expected to reach USD 2.34 billion by 2029, growing at a CAGR of 9.70% during the forecast period (2024-2029).

The ongoing Covid-19 pandemic is expected to have a significant impact on the studied market. The market growth was hampered by the decline in sales by major players in the initial phase of the pandemic due to the shutdown and closure of the manufacturing sites. For instance, according to a press release titled "Single-use Lead Times up to 12 Months as COVID Takes Its Toll" by one of the global market players ABEC in May 2021, few manufacturers have waited up to 1 year for single-use equipment, while vendors who are expanding capacities, these projects took months to come online. Thus, the sales of single-use bioreactors were affected by the pandemic. However, single-use bioprocess materials and systems were considered essential resources for the creation and distribution of possible vaccines and treatments for the disease. And, these platforms were used to make innovative vaccines, such as mRNA, DNA, and viral vectors, and were generally constructed using single-use technologies due to the speed and flexibility required. In the article 'COVID-19 Drives Surge in Growth of Single-use Technologies' published in July 2022 it was mentioned that biopharmaceutical companies sought out adaptable technologies that could be swiftly brought online to mass produce vaccines against the SARS-CoV-2 virus. As a result, COVID-19 marked a turning point for single-use systems (SUS), with a sharp rise in demand for reusable and adaptable technology for industrial manufacture. Therefore, such factors mentioned above indicate that the Covid-19 pandemic has had a significant impact on the market studied.

Certain factors that are driving the market's growth include rapid adoption of single-use technologies (SUTs) by the industry, cost-effectiveness, lower downtime, and the launch of new products.

Furthermore, the inclination of the industry toward using singleuse bioreactors (SUBs) is currently being influenced by the criticality of the step, the value of the product, and the time for product development and production. Additionally, as per the article 'Advancing upstream biomanufacturing: continuous perfusion cell culture' published in July 2022 it was mentioned that initial continuous perfusion process development frequently takes more time than batch and fed-batch processes. However, once the procedure is in practice, productivity gains might counterbalance this. These benefits include enabling manufacturers to reach clinical production quantities more readily by allowing for lesser scale-up production operational volume requirements. And these benefits can be achieved using single-use bioreactors. Therefore, such advantages in manufacturing facilities that are gained by using single-use bioreactors are anticipated to contribute to market growth.

In the bioprocessing sector, SUBs has become a standard for both clinical and industrial batches. Thus, significant developments are being made in the single-use bioreactor segment which is also fuelling the market growth. For instance, in March 2021, Thermo Fischer Scientific launched the 3,000 L and 5,000 L HyPerforma DynaDrive single-use bioreactors. The 3,000 L and 5,000 L vessels in this product have the same footprint, with hardware that is simplified and optimized for perfusion cell culture procedures to assist conserve manufacturing suite space. Thus, such developments are anticipated to drive market growth over the forecast period.

Therefore, owing to the above-mentioned factors the market is predicted to witness growth over the forecast period. However, high regular recurring expenses may be involved which is anticipated to hinder the market growth.

Single Use Bioreactor Industry Segmentation

As per the scope of the report, single-use bioreactors (SUBs), also known as disposable bioreactors, have now become an integral part of biotechnology manufacturing facilities. The single-use bioreactor market is segmented by Type of Product (Single-use Bioreactor Systems, Media Bags, Filtration Assemblies, and Other Products), Cell Type (Mammalian Cell, Bacteria, Yeast, and Other Cell Types), Molecule Type (Vaccines, Monoclonal Antibodies, Stem Cells, Recombinant Proteins and Other Molecule Types), End User (Pharmaceutical and Biopharmaceutical Industries, Contract Research Organizations (CRO) and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Type of Product
Single-use Bioreactor Systems
Media Bags
Filtration Assemblies
Other Products
By Cell Type
Mammalian Cell
Bacteria
Yeast
Other Cell Types
By Molecule Type
Vaccines
Monoclonal Antibodies
Stem Cells
Recombinant Proteins
Other Molecule Types
By End User
Pharmaceutical and Biopharmaceutical Industries
Contract Research Organizations (CRO)
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Single-use Bioreactor Market Size Summary

The single-use bioreactor market is poised for significant growth, driven by the rapid adoption of single-use technologies across the biopharmaceutical industry. These technologies offer cost-effectiveness, reduced downtime, and the ability to quickly scale up production, making them increasingly attractive for both clinical and industrial applications. The COVID-19 pandemic acted as a catalyst for this market, highlighting the need for flexible and adaptable manufacturing solutions to meet the urgent demand for vaccines and therapeutics. The pandemic's impact was initially challenging, with delays in equipment availability, but it ultimately underscored the importance of single-use systems in bioprocessing. The market is further bolstered by ongoing innovations and product launches, such as Thermo Fischer Scientific's introduction of large-scale single-use bioreactors, which are designed to optimize space and enhance production efficiency.

North America is expected to dominate the single-use bioreactor market, driven by a high prevalence of chronic diseases and a robust pipeline of drug development activities. The region's extensive network of FDA-registered facilities for biologics and human drugs presents significant opportunities for the adoption of single-use technologies. The pharmaceutical and biopharmaceutical sectors are rapidly advancing in drug development, with numerous vaccine candidates in various trial phases, which is anticipated to fuel demand for single-use bioreactors. The competitive landscape is marked by the presence of major players like ABEC, Celltainer, and Thermo Fisher Scientific, who are actively expanding their capabilities and forming strategic partnerships to enhance their market positions. These developments, coupled with the increasing demand for monoclonal antibodies and the need for efficient manufacturing processes, are expected to drive the market's growth over the forecast period.

Explore More

Global Single-use Bioreactor Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rapid Adoption of Single-use Technologies (SUTs) by the Industry

      2. 1.2.2 Cost Effectiveness and Lower Downtime

      3. 1.2.3 New Product Launches

    3. 1.3 Market Restraints

      1. 1.3.1 High Regular Recurring Expenses

      2. 1.3.2 Issues with Meeting the Standards of Good Manufacturing Practices

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Type of Product

      1. 2.1.1 Single-use Bioreactor Systems

      2. 2.1.2 Media Bags

      3. 2.1.3 Filtration Assemblies

      4. 2.1.4 Other Products

    2. 2.2 By Cell Type

      1. 2.2.1 Mammalian Cell

      2. 2.2.2 Bacteria

      3. 2.2.3 Yeast

      4. 2.2.4 Other Cell Types

    3. 2.3 By Molecule Type

      1. 2.3.1 Vaccines

      2. 2.3.2 Monoclonal Antibodies

      3. 2.3.3 Stem Cells

      4. 2.3.4 Recombinant Proteins

      5. 2.3.5 Other Molecule Types

    4. 2.4 By End User

      1. 2.4.1 Pharmaceutical and Biopharmaceutical Industries

      2. 2.4.2 Contract Research Organizations (CRO)

      3. 2.4.3 Other End Users

    5. 2.5 Geography

      1. 2.5.1 North America

        1. 2.5.1.1 United States

        2. 2.5.1.2 Canada

        3. 2.5.1.3 Mexico

      2. 2.5.2 Europe

        1. 2.5.2.1 Germany

        2. 2.5.2.2 United Kingdom

        3. 2.5.2.3 France

        4. 2.5.2.4 Italy

        5. 2.5.2.5 Spain

        6. 2.5.2.6 Rest of Europe

      3. 2.5.3 Asia-Pacific

        1. 2.5.3.1 China

        2. 2.5.3.2 Japan

        3. 2.5.3.3 India

        4. 2.5.3.4 Australia

        5. 2.5.3.5 South Korea

        6. 2.5.3.6 Rest of Asia-Pacific

      4. 2.5.4 Middle East and Africa

        1. 2.5.4.1 GCC

        2. 2.5.4.2 South Africa

        3. 2.5.4.3 Rest of Middle East and Africa

      5. 2.5.5 South America

        1. 2.5.5.1 Brazil

        2. 2.5.5.2 Argentina

        3. 2.5.5.3 Rest of South America

Global Single-use Bioreactor Market Size FAQs

The Global Single-use Bioreactor Market size is expected to reach USD 1.47 billion in 2024 and grow at a CAGR of 9.70% to reach USD 2.34 billion by 2029.

In 2024, the Global Single-use Bioreactor Market size is expected to reach USD 1.47 billion.

Single Use Bioreactor Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)